top of page
Search
Visit PreciGenome at ASGCT 2026 in Boston — Booth #1363
Pre-conference announcement | ASGCT 29th Annual Meeting | May 11–15, 2026 | Boston Convention & Exhibition Center | Booth #1363 PreciGenome is pleased to announce our participation in the American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting, taking place May 11–15, 2026 at the Boston Convention & Exhibition Center in Boston, Massachusetts. ASGCT is the world's premier scientific gathering for the gene and cell therapy community, bringing together academic inves
May 10
3D Environment with BMP-2-Releasing Nanocarriers Enhances Osteogenic Commitment of Human Tendon Stem Cells
Researchers at the University of Salerno developed BMP-2-loaded PLGA nanocarriers embedded in 3D-bioprinted GelMA hydrogel scaffolds to drive osteogenic differentiation of human tendon stem/progenitor cells under dynamic perfusion culture using the iFlow bioreactor system.
May 3
Whole-Body Pharmacokinetics of Lipid, mRNA and Translated Protein Following Intravenous Administration of Spike Protein Expressing mRNA-LNP in Mice
A comprehensive whole-body pharmacokinetic study tracking all three mRNA-LNP components—ionizable lipid ALC-0315, mRNA, and translated spike protein—across plasma and 10 tissues over 14 days in mice, formulated using the PreciGenome NanoGenerator Flex-M microfluidic mixer.
Apr 25
Impact of Cell Line and Reporter Gene Selection on In-Vitro mRNA-LNP Transfection Evaluation
Technical review of Lu et al. (AAPS Open, 2025) examining how cell line and reporter gene choices affect mRNA-LNP transfection assays. The study compares Jurkat, L-929, and HEK 293T cells with luciferase vs. eGFP reporters, using LNPs formulated on the PreciGenome NanoGenerator Flex-M microfluidic platform.
Apr 19
Peripheral mRNA-LNP Vaccination Generates Protective Brain-Resident Memory T Cells Against Intracranial Tumors
Peripheral mRNA-LNP vaccination generates tumor-specific brain-resident memory CD8+ T cells that durably protect mice against intracranial melanoma and glioblastoma. Published in the Journal of Clinical Investigation by Mix et al. (University of Iowa). LNPs formulated using PreciGenome NanoGenerator Flex.
Apr 18
bottom of page